Metabolic Complications Cardiovascular Disease / CholesterolTriglycerides / Diabetes / Insulin Resistance / Hyperlipidemia / Myocardial Infarction
Ongoing HIV Replication during Treatment Interruption Is Associated with Inflammatory and Cardiovascular Risk Markers6-5-2009GlaxoSmithKline Meta-analysis Does Not Show Elevated Cardiovascular Risk Associated with Use of abacavir (Ziagen, Epzicom)5/19/09 Metabolic and Body Shape Abnormalities Are Common in Children and Youth with HIV5/15/09Natural Hormone Leptin Improves Blood Lipid Levels and Insulin Sensitivity and Decreases Abdominal Fat in People with HIV5/08/09Study Shows High Prevalence of Metabolic Syndrome and Associated Cardiovascular Risk in Older HIV Patients 1/13/09Ezetimibe (Zetia) Reduces Bad LDL Cholesterol in HIV Positive People on HAART 10/17/08Blood Lipid Profiles Improve after CD4-guided Treatment Interruption 9/25/08SMART Researchers Publish Findings Showing Abacavir (Ziagen) Is Associated with Elevated Risk of Cardiovascular Disease 9/09/2008Management of Elevated Blood Lipids May Be Less Successful in HIV Patients with High Cardiovascular Risk 9/09/2008Does Raltegravir (Isentress) Worsen Depression in HIV Patients with a History of Treatment for Depression? 9/05/08Levels of Osteopontin Protein Are Elevated in People with HIV-associated Dementia 9/05/08FDA Announces Changes to Ritonavir (Norvir) Label to Reflect New Data on Heart Rhythm Abnormalities 9/05/08Coronary Heart Disease, HIV Infection, and Antiretroviral Therapy 8/22/08 Studies Look at Association between CD4 Cell Count and Cardiovascular Risk in People with HIV 8/22/08Does Abacavir (Ziagen) Raise Heart Attack Risk? Conflicting Answers from SMART and 54-study Pooled Analysis 8/12/08Does Abacavir (Ziagen) Raise Heart Attack Risk? Conflicting Answers from SMART and 54-study Pooled Analysis 8/12/08Experts Recommend Cardiovascular Risk Screening for People with HIV 7/08/08HIV Positive Children and Adolescents Have Elevated Risk of Cardiovascular Disease 7/08/08Studies Find Minimal Cardiovascular Benefit and Increased Mortality with Intensive Glucose Management for People with Type 2 Diabetes 6/20/08 High-density Lipoprotein (HDL) Cholesterol in People with HIV: Association with Viral Load and Antiretroviral Therapy 6/03/08Ezetimibe Combined with Low-dose Statin Drugs Effectively Reduces Low Density Lipoprotein (LDL) in HIV Patients on Protease Inhibitors 6/03/08Controlling Cholesterol with Statins 5/23/08 Does Tenofovir (Viread) Increase Liver Toxicity Related to Efavirenz (Sustiva)? 5/16/08 Body Fat and Blood Lipid Levels in Men and Women with HIV 5/16/08 Body Shape Changes in HIV Positive and HIV Negative Women 5/16/08
Worsening Cardiovascular Risk among HIV Positive Individuals in D:A:D Study Has Not Led to an Increase in Heart Attacks 5/13/08 Interaction between Lopinavir-ritonavir (Kaletra) and Rosuvastatin (Crestor) Reduces Drug's Lipid-lowering Effect 5/13/08 Persistent AIDS-related Kaposi Sarcoma in the HAART Era Reveals Need for New Therapies 5/09/08 Large Study Finds Several Types of Non-AIDS-defining Cancer Are More Common in HIV Positive People 5/30/08 Interrupting Antiretroviral Therapy Does Not Reduce the Risk of Cardiovascular Disease: Final Results of ACTG 5102 4/29/08
Fish Oil with or without Fenofibrate Reduces Elevated Triglycerides in HIV Patients on HAART 4/18/08 Elevated Fibrinogen Levels Linked to Protease Inhibitors May Contribute to Elevated Cardiovascular Risk 4/15/08 Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children 4/04/08
Fuzeon
(enfuvirtide,
T-20) Selzentry
(maraviroc)